Author:
Panagiotis Pavlou,Congleton Jo
Abstract
AbstractCommentary on:Janson C, Menzies-Gow A, Nan C,et al. SABINA: an overview of short-acting β2-agonist use in asthma in European countries.Adv Ther. 2020;37:1124–35.Series co-ordinator:Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George’s, University of London, UK
Subject
Pharmacology (medical),General Medicine
Reference11 articles.
1. SABINA: An Overview of Short-Acting β 2 -Agonist Use in Asthma in European Countries;Janson;Adv Ther,2020
2. SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma
3. Asthma UK . What is asthma? [online], 2021. Available: https://www.asthma.org.uk/advice/understanding-asthma/what-is-asthma/ [Accessed 8 Dec 2021].
4. Global Initiative for Asthma . Global strategy for asthma management and prevention, 2020 [online], 2021. Available: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf [Accessed 8 Dec 2021].
5. British Thoracic Society, Scottish Intercollegiate Guidelines Network . BTS/SIGN British guideline on the management of asthma [online], 2019. Available: https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/ [Accessed 8 Dec2021].